Across Europe , interest surrounding copyright as a option for mental health conditions is surging. While historically viewed primarily as an anesthetic agent, its potential in treating mood disorders, particularly severe cases, is fueling a notable shift in healthcare. Despite this, availability stays complex and changes widely between European na